Evidence map›Paper›PMID 27555772›Full record

ArticleInternational journal of nanomedicine2016

The synergistic radiosensitizing effect of tirapazamine-conjugated gold nanoparticles on human hepatoma HepG2 cells under X-ray irradiation.

Xi Liu, Yan Liu, Pengcheng Zhang, Xiaodong Jin, Xiaogang Zheng, Fei Ye, Weiqiang Chen, Qiang Li

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Metal-basedTheranostics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xi LiuInstitute of Modern Physics; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences; Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou; School of Life Science, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Yan LiuInstitute of Modern Physics; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences; Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou; School of Life Science, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Pengcheng ZhangInstitute of Modern Physics; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences; Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou; School of Life Science, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Xiaodong JinInstitute of Modern Physics; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences; Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou.
Xiaogang ZhengInstitute of Modern Physics; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences; Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou; School of Life Science, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Fei YeInstitute of Modern Physics; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences; Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou; School of Life Science, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Weiqiang ChenInstitute of Modern Physics; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences; Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou.
Qiang LiInstitute of Modern Physics; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences; Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou.
University of Chinese Academy of Sciences · CNInstitute of Modern Physics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reductive drug-functionalized gold nanoparticles (AuNPs) have been proposed to enhance the damage of X-rays to cells through improving hydroxyl radical production by secondary electrons. In this work, polyethylene glycol-capped AuNPs were conjugated with tirapazamine (TPZ) moiety, and then thioctyl TPZ (TPZs)-modified AuNPs (TPZs-AuNPs) were synthesized. The TPZs-AuNPs were characterized by transmission electron microscopy, ultraviolet-visible spectra, dynamic light scattering, and inductively coupled plasma mass spectrometry to have a size of 16.6±2.1 nm in diameter and a TPZs/AuNPs ratio of ~700:1. In contrast with PEGylated AuNPs, the as-synthesized TPZs-AuNPs exhibited 20% increment in hydroxyl radical production in water at 2.0 Gy, and 19% increase in sensitizer enhancement ratio at 10% survival fraction for human hepatoma HepG2 cells under X-ray irradiation. The production of reactive oxygen species in HepG2 cells exposed to X-rays in vitro demonstrated a synergistic radiosensitizing effect of AuNPs and TPZ moiety. Thus, the reductive drug-conjugated TPZs-AuNPs as a kind of AuNP radiosensitizer with low gold loading provide a new strategy for enhancing the efficacy of radiation therapy.

Indexed as

Metal NanoparticlesGoldHep G2 CellsHumansHydroxyl RadicalMicroscopy, Electron, TransmissionPolyethylene GlycolsRadiation-Sensitizing AgentsTirapazamineTriazinesTumor MicroenvironmentX-RaysGoldHydroxyl RadicalPolyethylene GlycolsRadiation-Sensitizing AgentsTirapazamineTriazinesAuNPshuman hepatoma cellshydroxyl radical productionradiation enhancementsynergistic effect

Identifiers

PMID27555772
PMCPMC4970453
OpenAlexW2494310178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.